C13ORF37 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.273000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.452000E-01
Normal-vs-Stage2
4.353000E-01
Normal-vs-Stage3
9.010800E-01
Normal-vs-Stage4
3.897200E-01
Stage1-vs-Stage2
8.381400E-01
Stage1-vs-Stage3
2.613600E-01
Stage1-vs-Stage4
7.568600E-01
Stage2-vs-Stage3
3.009200E-01
Stage2-vs-Stage4
9.082200E-01
Stage3-vs-Stage4
4.429000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.230800E-01
Normal-vs-AfricanAmerican
6.047200E-01
Normal-vs-Asian
5.650800E-01
Caucasian-vs-AfricanAmerican
4.800400E-01
Caucasian-vs-Asian
5.897000E-01
AfricanAmerican-vs-Asian
7.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.884000E-01
Normal-vs-Female
4.628000E-01
Male-vs-Female
7.393000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.543400E-01
Normal-vs-Age(41-60Yrs)
2.470000E-01
Normal-vs-Age(61-80Yrs)
5.050800E-01
Normal-vs-Age(81-100Yrs)
4.281400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.186600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.971400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.033400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.083400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.058800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.558400E-01
Normal-vs-Daily Drinker
4.487000E-01
Normal-vs-Weekly Drinker
6.210000E-01
Normal-vs-Occasional Drinker
1.448950E-01
Normal-vs-Social Drinker
4.873600E-01
Non Drinker-vs-Daily Drinker
9.162600E-01
Non Drinker-vs-Weekly Drinker
6.079800E-01
Non Drinker-vs-Occasional Drinker
1.279820E-01
Non Drinker-vs-Social Drinker
9.949000E-01
Daily Drinker-vs-Weekly Drinker
4.974800E-01
Daily Drinker-vs-Occasional Drinker
1.322600E-01
Daily Drinker-vs-Social Drinker
9.151000E-01
Weekly Drinker-vs-Occasional Drinker
4.275600E-02
Weekly Drinker-vs-Social Drinker
5.925400E-01
Occasional Drinker-vs-Social Drinker
1.452810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.345580E-01
Normal-vs-Grade 2
7.062000E-02
Normal-vs-Grade 3
1.028420E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.107200E-01
Grade 1-vs-Grade 3
2.898400E-01
Grade 1-vs-Grade 4
1.345580E-01
Grade 2-vs-Grade 3
3.478000E-01
Grade 2-vs-Grade 4
7.062000E-02
Grade 3-vs-Grade 4
1.028420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.699400E-01
Normal-vs-NonDiabetic
3.794600E-01
Diabetic-vs-NonDiabetic
2.380000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.793400E-01
Normal-vs-NoPancreatitis
4.237000E-01
Pancreatitis-vs-NoPancreatitis
1.439970E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.790200E-01
Normal-vs-N1
4.461400E-01
N0-vs-N1
5.382600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.163000E-04
Normal-vs-TP53-NonMutant
4.973400E-01
TP53-Mutant-vs-TP53-NonMutant
2.809900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
